StockGlow

Aridis Pharmaceuticals, Inc. (ARDS)

Develops antibody drugs to treat dangerous bacterial and viral lung infections.

$0.00+0.00%Healthcare
Compare ARDS with
StockGlow Score
3
Bearish
BearishBullish
1 year ago+0.0%

The outlook

ARDS is trading at the very bottom of its 52-week range and well below both its 50- and 200-day moving averages, signaling a sustained downtrend. Analyst coverage appears minimal or absent. The overall sentiment leans heavily bearish based on current price positioning.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$4,457
52-wk high
$0.05
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—

Similar stocks

ATXIAvenue Therapeutics, Inc.$0.30+20.00%EVLOEvelo Biosciences, Inc.$0.00+0.00%KRBPQKiromic BioPharma, Inc.$0.00+0.00%GRTXDGalera Therapeutics, Inc.$15.57+2.10%ADILAdial Pharmaceuticals, Inc.$2.95+4.98%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy